Home/Filings/4/0000899243-23-006211
4//SEC Filing

Alloway Paul 4

Accession 0000899243-23-006211

CIK 0001661998other

Filed

Feb 26, 7:00 PM ET

Accepted

Feb 27, 4:05 PM ET

Size

8.0 KB

Accession

0000899243-23-006211

Insider Transaction Report

Form 4
Period: 2023-02-23
Alloway Paul
See Remarks
Transactions
  • Award

    Employee Stock Option (Right to Buy)

    2023-02-23+164,000164,000 total
    Exercise: $1.60Exp: 2033-02-23Common Stock (164,000 underlying)
  • Award

    Restricted Stock Units

    2023-02-23+27,00027,000 total
    Common Stock (27,000 underlying)
Footnotes (3)
  • [F1]The option vests in 48 substantially equal monthly installments upon the Reporting Person's completion of each full month of service following January 1, 2023.
  • [F2]Each restricted stock unit represents a contingent right to receive one share of Issuer common stock. The restricted stock units have no expiration date.
  • [F3]The restricted stock units will vest and settle as to one third of the restricted stock units on each of the first three anniversaries of January 1, 2023 so that such RSUs will become fully vested on January 1, 2026.

Issuer

Homology Medicines, Inc.

CIK 0001661998

Entity typeother

Related Parties

1
  • filerCIK 0001916155

Filing Metadata

Form type
4
Filed
Feb 26, 7:00 PM ET
Accepted
Feb 27, 4:05 PM ET
Size
8.0 KB